15 March 2017 - Deborah Wilkes
Archived
Galenica said it aimed to complete its planned separation into two independent, listed companies "during the second quarter of 2017", assuming market conditions remained stable. The Swiss company also promised to strengthen the presence of its Vifor Consumer Health business both at home and abroad.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.